The Zelar City Summit 2025 brought together leading scientists, physicians, and biotech founders to discuss the frontiers of longevity science — from gene therapy and organ replacement to cryonics. Unlimited Bio COO Vladimir Leshko attended the event, sharing updates on the company’s progress and insights into the evolving landscape of human lifespan extension.
“Nothing yet reliably works in humans — so we have a lifetime of work ahead. Hopefully, slightly less than a lifetime,” said Vladimir.
Highlights from the Summit
Vladimir Leskho also presented Unlimited Bio’s VEGF and gene therapy cocktail approach, emphasizing the company’s mission to move beyond theory toward actionable rejuvenation technologies.
“Nothing yet reliably works in humans — so we have a lifetime of work ahead. Hopefully, slightly less than a lifetime,” said Vladimir.
Highlights from the Summit
- Frontiers of Longevity. Topics included organ replacement, combination (gene) therapies, and cryonics — positioned as complementary pillars of life-extension research.
- Scientific Discussions. Vladimir Leshko exchanged views with longevity pioneers: George Church on self-administration ethics, Morten Scheibye-Knudsen on running low-cost human aging RCTs, Dr. Oliver Zolman on predictions for the XPRIZE Healthspan race.
- Resilience & Dedication. Ilia Stambler delivered his talk from Israel despite a missile alert — a moment that impressed attendees with his commitment.
- Emerging Research. Presentations covered DNA repair, anti-tumor bacteria (Sam Sharifi, PhD), low-cost animal studies (Kevin Perez), and aging research pitfalls (Justin R.).
- Cryonics in Focus. Tomorrow Biostasis GmbH showcased its pioneering “cryo-ambulance” concept — soon expanding operations to The Hague.
- Diagnostics & Innovation. Dx365 demonstrated affordable rapid diagnostics for HbA1c, testosterone, and ferritin, led by Filipp Mitrofanov.
Vladimir Leskho also presented Unlimited Bio’s VEGF and gene therapy cocktail approach, emphasizing the company’s mission to move beyond theory toward actionable rejuvenation technologies.